Evidence map›Paper›PMID 28528509›Full record

ArticleVirchows Archiv : an international journal of pathology2017

Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases.

Gábor Cserni, Giuseppe Floris, Nektarios Koufopoulos, Anikó Kovács, Afroditi Nonni, Peter Regitnig, Anders Stahls, Zsuzsanna Varga

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 7 countries.

Gábor CserniDepartment of Pathology, Bács-Kiskun County Teaching Hospital, Nyíri út 38, Kecskemét, 6000, Hungary. cserni@freemail.hu.ORCID http://orcid.org/0000-0003-1344-7744
Giuseppe FlorisDepartment of Imaging and Pathology, Laboratory of Translational Cell and Tissue Research, KU Leuven-University of Leuven, Herestraat 49, 3000, Leuven, Belgium.
Nektarios KoufopoulosDepartment of Pathology, "Saint Savvas" Anticancer Hospital of Athens, 171 Alexandras av, 115 22, Athens, Greece.
Anikó KovácsDepartment of Clinical Pathology and Genetics, Sahlgrenska University Hospital, Gula stråket 8, 41 345, Gothenburg, Sweden.
Afroditi NonniFirst Department of Pathology, Medical School, National and Kapodistrian University of Athens, Mikras Asias Str. 75, 115 27, Athens, Greece.
Peter RegitnigInstitute of Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036, Graz, Austria.
Anders StahlsDepartment of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, P.O. Box 400, 00029, Helsinki, Finland.
Zsuzsanna VargaDepartment of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zürich, Switzerland.
KU Leuven · BEMedical University of Graz · ATNational and Kapodistrian University of Athens · GRSahlgrenska University Hospital · SESt Savas Hospital · GRUniversity Hospital of Zurich · CHUniversity of Helsinki · FIUniversity of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive lobular carcinoma of the breast is known to produce intracellular mucin and has been recognized in single-case reports to show extracellular mucin production, as well. This latter morphology is not only rare but must also be under- or misdiagnosed. The aim was to better characterize this entity. Cases of lobular cancers demonstrating extracellular mucin formation were identified in a multi-institutional effort and their clinical and morphologic features were assessed. Immunohistochemistry was used to characterize the E-cadherin-membrane complex, neuroendocrine differentiation, and to some extent, mucin formation. All but one of the eight cases occurred in postmenopausal patients. Extracellular mucin production was present in 5 to 50% of the tumour samples and rarely also appeared in nodal and distant metastases. The tumours were completely E-cadherin negative and showed cytoplasmic p120 positivity. The majority (n = 6/8) was also completely negative for β-catenin, but two tumours displayed focal β-catenin positivity in the mucinous area. MUC1 and MUC2 expression was observed in all and 7/8 tumours, respectively; neuroendocrine differentiation was present in only one. Invasive lobular carcinoma with extracellular mucin formation is a rare morphologic variant of lobular carcinoma prone to be misdiagnosed and warranting further studies.

Indexed as

AdultAgedBiomarkers, TumorBreast NeoplasmsCarcinoma, LobularFemaleHumansMiddle AgedMucin-1Mucin-2Biomarkers, TumorMUC2 protein, humanMucin-1Mucin-2Breast cancerE-cadherinExtracellular mucinLobular carcinomaMucinous carcinoma

Identifiers

PMID28528509
OpenAlexW2615960427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.